Skip to main content
Supplement ScienceSupplementScience
meta analysis2,160 participants

Omega-3s for Depression: What the Meta-Analyses Show

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

A 2019 meta-analysis (26 randomized trials, 2,160 participants) found omega-3 supplements were associated with reduced...

A 2019 meta-analysis (26 randomized trials, 2,160 participants) found omega-3 supplements were associated with reduced depressive symptoms — but the benefit was specific to formulations with at least 60% EPA (eicosapentaenoic acid). EPA-predominant omega-3 is studied as a possible adjunct, often alongside standard care, and is not a substitute for depression treatment.

Key Findings

  • Across 26 double-blind RCTs (2,160 participants), omega-3 supplements with ≥60% EPA were associated with reduced depressive symptoms (standardized mean differences around −0.50 to −1.03 depending on formulation).
  • DHA-predominant formulations did not show the same benefit — the effect was tied specifically to higher-EPA preparations.
  • Omega-3 was often studied as an add-on to standard antidepressant care rather than as a replacement.
  • Heterogeneity was high (differences in baseline depression, dose, and omega-3 status), so results should be interpreted with caution.

Study Details

Efficacy of omega-3 PUFAs in depression: A meta-analysis
Liao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, et al.Translational Psychiatry (2019)
Omega-3 formulations with ≥60% EPA were associated with significant reductions in depressive symptoms; DHA-predominant formulations were not.
2,160 participantsModerate

Practical Takeaway

Omega-3 fatty acids — specifically EPA-predominant formulations (at least 60% EPA) — have been studied for supporting mood, with meta-analyses linking them to reduced depressive symptoms, frequently as an add-on to usual care. DHA-heavy products did not show the same association. This is supportive information, not a treatment plan: omega-3 is not a substitute for evidence-based depression care. If you are experiencing depression — and especially if you have any thoughts of self-harm — please reach out to a healthcare professional, and review supplements with your clinician, particularly if you take blood thinners.

Summary

Meta-analyses report that omega-3 supplements rich in EPA were associated with reduced depressive symptoms, with the benefit tied specifically to higher-EPA formulations.

Related Supplements

Related Conditions

Product Reviews

Learn More

Frequently Asked Questions

Do omega-3s help with depression?

Meta-analyses found omega-3 supplements were associated with reduced depressive symptoms, but the benefit was specific to formulations high in EPA (at least 60%). It is studied mainly as a possible add-on to standard care, not as a standalone treatment.

Is EPA or DHA better for mood?

The evidence points to EPA. Higher-EPA formulations were associated with antidepressant effects, while DHA-predominant products were not. If choosing a product for mood, the EPA content is the key number to check.

Can omega-3 replace my antidepressant?

No. Much of the research studied omega-3 as an add-on to usual care, not a replacement. Do not stop or change a prescribed antidepressant on your own — make any changes with your clinician.

When should I seek help for depression?

If low mood is persistent, worsening, or affecting your daily life — or if you have any thoughts of harming yourself — please contact a healthcare professional or a crisis line right away. Supplements are not a substitute for proper care.

Continue Reading

References

  1. Liao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, et al. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. DOI PubMed
  2. Martins JG (2009). EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. Journal of the American College of Nutrition. DOI PubMed